ED50: <0.2 µg/ml, as determined by its ability to inhibit the TNF-a mediated cytotoxicity in the L-929 cells, corresponding to a specific activity of >5000 IU/mg in the presence of 0.25 ng/ml of rHuTNF-a.
Purity
>97% as determined by SDS-PAGE.
Product Form
Lyophilized
Concentration
Reconstitution dependent.
Formulation
Lyophilized from Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at ambient temperature. Lyophilized: Short term (3 weeks) store at 25°C. Long term store desiccated below -18°C. Reconstituted: Short term (2-7 days) store at 4°C. Long term store below -18°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Human TNF Receptor II Protein (A61732)? Please let us know so that we can list the citation on this page.
Alternative products to Recombinant Human TNF Receptor II Protein (A61732)
